Separate promising research from proven care.
posted on
By the Regenerative Evidence Guide Team An adverse event report is a description of a health problem someone experienced after using a medical product, filed with a regulator like the FDA. A single …
Continue Reading about Adverse Event Reports and Safety Evidence: What Each Can—and Cannot—Show →
posted on
By the Regenerative Evidence Guide Team Research consent is the process of learning what a clinical study involves — its purpose, risks, benefits, and alternatives — before you agree to take part. If …
Continue Reading about Research Consent for a Clinical Study: What to Ask First →
posted on
By the Regenerative Evidence Guide Team Regenerative medicine terms like "stem cells," "tissues," and "biological products" are specific regulatory categories, not proof that a treatment works. A stem …
posted on
By the Regenerative Evidence Guide Team Are Exosome Products FDA-Approved? The Short Answer No exosome product is currently approved by the U.S. Food and Drug Administration (FDA) for sale in the …
Continue Reading about Exosome Products: Regulatory Questions and Safety Boundaries →
posted on
By the Regenerative Evidence Guide Team What Is a Systematic Review in Regenerative Medicine? A systematic review in regenerative medicine gathers every relevant study on one question and uses a …
posted on
By the Regenerative Evidence Guide Team What Counts as a Regenerative Medicine Side Effect or Product Concern? If you had a regenerative-medicine procedure — such as a stem cell injection, …
Continue Reading about Reporting a Regenerative Medicine Side Effect (FDA Guide) →